Novo Nordisk

cardiovascular disease
Biotech

Novo calls off $598M Heartseed collab, citing 'strategic reviews'

Japanese biotech Heartseed said it was "difficult to reasonably foresee" that Novo would scrap the 2021 deal, despite the pharma's restructuring.
Zoey Becker Sep 30, 2025 1:55pm
Numbers and boxes floating on a blue digital background

One-third of data collected in trials may be unnecessary: study

Sep 19, 2025 11:01am
weight loss scale weigh measure tape obesity overweight

Lilly rounds out orforglipron data ahead of obesity filings

Sep 17, 2025 9:00am
obesity overweight weight loss weigh

Novo pushes ahead with amylin after seeing ph. 3 tolerability

Sep 16, 2025 8:12am
Novo Nordisk
Favicon Fierce Pharma

Novo Nordisk tells employees they must return to office Jan. 1

Sep 11, 2025 2:13pm
Doustdar
Favicon Fierce Pharma

Novo charts major restructuring, layoffs under new CEO

Sep 10, 2025 8:41am